Complications associated with primary and secondary perforation of the bladder following immediate instillations of epirubicin after transurethral resection of superficial urothelial tumours

International Urology and Nephrology

Volumn 41, Issue 4, 2009, Pages 865-868

  Tyritzis, S I ^a   Stravodimos, Konstantinos G ^a   Mihalakis, A ^a   Constantinides, Constantinos A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Complications; Epirubicin; Intravesical chemotherapy; Perforation bladder tumour

Indexed keywords

CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; EPIRUBICIN; INFUSION FLUID; METRONIDAZOLE;

ABDOMINAL DISEASE; AGED; ARTICLE; BLADDER CATHETERIZATION; BLADDER PERFORATION; BLADDER SURGERY; BLADDER TUMOR; CASE REPORT; CELLULITIS; CONSERVATIVE TREATMENT; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG TOLERABILITY; DYSURIA; FEVER; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; MALAISE; MALE; POSTOPERATIVE CARE; SUTURING METHOD; TREATMENT RESPONSE; TUMOR LOCALIZATION; URINARY URGENCY; UROGENITAL TRACT CANCER;

ADMINISTRATION, INTRAVESICAL; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; CYSTOSCOPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; FOLLOW-UP STUDIES; HUMANS; IATROGENIC DISEASE; MALE; RISK ASSESSMENT; RUPTURE; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME; URETHRA; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES, MALE; WOUNDS, PENETRATING;

EID: 77954563048     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9536-y     Document Type: Article

References (7)

1. Oosterlinck W, Kurth KH, Schröder F, Bultinck J, Hammond B, Sylvester R (1993) A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J Urol 149:749-752
2. Rajala P, Kaasinen E, Raitanen M, Liukkonen T, Rintala E (2002) Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study-Finnbladder III long-term results. J Urol 168:981-985. doi:10.1016/S0022-5347(05)64556-9 Finnbladder Group
3. Sylvester RJ, Oosterlinck W, van der Meijden AP (2004) Single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171:2186-2190. doi:10.1097/01.ju. 0000125486.92260.b2 (Pubitemid 38625431)
4. Oddens JR, van der Meijden AP, Sylvester R (2004) One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients. Is it always safe? Eur Urol 46:336-338. doi:10.1016/j.eururo.2004.05. 003 (Pubitemid 39078567)
5. Doherty AP, Trendell-Smith N, Stirling R, Rogers H, Bellringer J (1999) Perivesical fat necrosis after adjuvant intravesical chemotherapy. BJU Int 83:420-423. doi:10. 1046/j.1464-410x.1999.00951.x
6. Cliff AM, Romaniuk CS, Parr NJ (2000) Perivesical inflammation after early mitomycin C instillation. BJU Int 85:556-557. doi:10.1046/j.1464-410x. 2000.00539.x (Pubitemid 30142641)
7. Ohguchi N, Sakaida N, Okamura A, Kawakita S, Kawamura H, Matsuda T (1997) Extravesical tumor implantation caused by perforation during transurethral resection of a bladder tumor: a case report. Int J Urol 4:516-518. doi:10.1111/j.1442-2042.1997.tb00296.x